← Back to Search

Group Language Therapy for Aphasia

N/A
Waitlist Available
Led By Dana Moser, Ph.D
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of adult-onset aphasia
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week post-intervention
Awards & highlights

Study Summary

This trial will study the effects of group participation on adults with aphasia.

Who is the study for?
This trial is for adults over 18 who were proficient in English before having a stroke that led to aphasia, impacting their language abilities. They must have good enough vision and hearing for assessments but can't join if they had childhood speech issues, major psychiatric illnesses, cognitive impairments, or other neurological disorders.Check my eligibility
What is being tested?
The study tests the effectiveness of group sessions focused on improving reading and writing skills in individuals with aphasia due to stroke. Participants will undergo language ability assessments before and after attending weekly 90-minute reading group sessions for an academic semester.See study design
What are the potential side effects?
Since this intervention involves educational activities rather than medical treatments, traditional side effects are not applicable. However, participants may experience fatigue or frustration during the learning process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with aphasia as an adult.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-week post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-week post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reading Comprehension Battery for Aphasia-2 (RCBA-2; LaPointe & Horner, 1998) Scores
Secondary outcome measures
Communication Confidence Rating Scale for Aphasia (CCRSA; Babbitt & Cherney, 2010)
Discourse Production Task
Gray Oral Reading Test (GORT; Wiederholt & Bryant, 2012)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Reading GroupExperimental Treatment1 Intervention
All participants in this group will receive language intervention within weekly group sessions and independent tasks with emphasis on improving reading and writing skills among persons with aphasia.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,313 Total Patients Enrolled
Dana Moser, Ph.DPrincipal InvestigatorUniversity of Arkansas

Media Library

Language intervention with group sessions and independent tasks Clinical Trial Eligibility Overview. Trial Name: NCT05520528 — N/A
Rehabilitation Research Study Groups: Reading Group
Rehabilitation Clinical Trial 2023: Language intervention with group sessions and independent tasks Highlights & Side Effects. Trial Name: NCT05520528 — N/A
Language intervention with group sessions and independent tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05520528 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant spots in this clinical trial for participants?

"Affirmative. According to information available on clinicaltrials.gov, this trial was first posted on September 1st 2022 and has been actively searching for patients since then. 40 participants need to be enrolled at one site in order for the study to be completed."

Answered by AI

What is the approximate size of the cohort participating in this trial?

"Affirmative, the details hosted on clinicaltrials.gov demonstrate that this medical research is currently gathering participants. It was initially posted on September 1st 2022 and was recently updated on August 25th 2022. 40 patients need to be recruited from a single site for this trial."

Answered by AI
~2 spots leftby May 2024